Metagenomic Contamination Control: Best Practices for Clean Data

Metagenomic sequencing detects nucleic acids from every organism in a sample, which makes it exceptionally sensitive to contamination from reagents, laboratory surfaces, other samples, and the surrounding environment. For students, researchers, analysts, and life-science professionals, contamination control is not an optional quality step but a core requirement for producing interpretable data. This article explains where contamination originates, how to detect it with negative controls and computational tools, and how to remove or account for it in your analysis pipeline. You will find a practical checklist for prevention, a troubleshooting guide for contaminated datasets, and clear criteria for when to escalate problems to a supervisor or collaborator.

Why Contamination Control Matters in Metagenomics

Metagenomic next-generation sequencing (mNGS) sequences all nucleic acids in a sample without targeting specific organisms. This untargeted approach enables detection of rare, unexpected, or fastidious pathogens that conventional methods miss, and it can identify multiple microorganisms simultaneously in mixed infections. However, the same sensitivity that makes mNGS powerful also makes it vulnerable to contamination. A single microbial read among millions of sequencing reads can be detected, so even trace amounts of foreign DNA can produce false-positive results.

The consequences of uncontrolled contamination are severe. In clinical diagnostics, false positives can lead to unnecessary treatment, while false negatives can delay appropriate therapy. In environmental and agricultural research, contamination distorts community composition estimates and leads to incorrect conclusions about microbial diversity and function. In low microbial biomass samples, such as cerebrospinal fluid, plasma, urine, or bronchoalveolar lavage fluid, contamination can comprise most of the sequenced reads, making genuine biological signals nearly impossible to distinguish from noise.

The EMBL-EBI Training resources emphasize that understanding your data begins with understanding your workflow. Similarly, the NCBI Data Resources provide reference databases and tools that depend on clean input data for reliable taxonomic classification. Contamination control is therefore a prerequisite for meaningful use of these public resources.

Sources of Contamination in Metagenomic Workflows

Contamination enters metagenomic datasets through three primary routes: reagent contamination, laboratory environment contamination, and cross-sample contamination. Each route requires different prevention and detection strategies.

Reagent Contamination

Reagent contamination refers to microbial DNA present in commercial kits, buffers, enzymes, water, and other laboratory supplies. DNA extraction kits are a well-documented source, as are PCR reagents and sequencing library preparation kits. Manufacturers cannot guarantee absolute sterility of biological reagents, and some products contain detectable levels of bacterial or fungal DNA.

Reagent contamination is particularly problematic in low microbial biomass studies because the ratio of contaminant DNA to sample DNA is high. A sample containing only nanograms of microbial DNA can be overwhelmed by contaminant DNA present at similar or higher concentrations in the reagents. The Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations review describes how contaminant DNA arises within microbiome studies and its negative impacts, especially during analysis of low biomass samples.

Laboratory Environment Contamination

Laboratory surfaces, air, and personnel contribute environmental contamination. Skin-associated bacteria such as Cutibacterium and Staphylococcus are common contaminants, as are soil and water-associated organisms that persist on surfaces or in reagents. Airborne contamination is a particular concern in clinical settings. A study of air infectious contamination during wound care in a burn intensive care unit used shotgun metagenomics to show that dressing removal aerosolized pathogens and antibiotic resistance genes, with the highest viral loads and bacterial diversity detected during intensive wound care procedures (Assessment of air infectious contamination during wound care in a burn intensive care unit using Shotgun metagenomics). This finding demonstrates that clinical procedures can generate measurable airborne microbial contamination, which has direct implications for sample handling in any laboratory.

Cross-Sample Contamination

Cross-sample contamination occurs when genetic material is exchanged between samples processed in parallel. This can happen during DNA extraction, library preparation, pooling, or sequencing. Index hopping, where sequencing adapters are misassigned between samples, is a well-known mechanism on certain sequencing platforms. Physical carryover through pipettes, shared reagents, or contaminated equipment is another common route.

Cross-contamination is a recognized phenomenon in molecular diagnostics. The Cont-ID: detection of sample cross-contamination in viral metagenomic data study notes that cross-contamination management was a key drawback during the development of PCR-based detection and is now adequately monitored in routine diagnostics. High-throughput sequencing faces similar difficulties due to its very high analytical sensitivity. As a single viral read can be detected among millions of sequencing reads, a detection threshold informed by estimated cross-contamination is mandatory.

The RIDE Checklist for Low Biomass Studies

The Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations review proposes a set of minimal experimental criteria called the RIDE checklist to improve the validity of low microbial biomass research. RIDE stands for:

• Reagents: Track and record reagent lots, and test new lots for contamination before use.
• Input: Document input material quantity and quality, and include extraction blanks.
• Distinguish: Use computational methods to distinguish true signals from contaminants.
• Evaluate: Assess contamination impact on study conclusions and report it transparently.

The RIDE checklist provides a practical framework for designing experiments that can withstand scrutiny. Each element addresses a specific contamination risk and produces records that support data interpretation.

Negative Controls: Design and Interpretation

Negative controls are samples that contain no biological input material but undergo the same processing as real samples. They are the foundation of contamination detection in metagenomics.

Types of Negative Controls

• Extraction blanks: These contain only extraction reagents and buffer, and they undergo the full DNA extraction protocol. They detect contamination introduced during extraction.
• Library preparation blanks: These contain water or buffer and undergo library preparation. They detect contamination introduced during library construction.
• Sequencing blanks: These are sequenced directly without prior processing. They detect contamination from sequencing reagents and instruments.
• Alien controls: These are synthetic or exogenous nucleic acids added to samples at known concentrations. They monitor recovery efficiency and can help distinguish true signals from contamination. The Cont-ID tool specifically requires at least one Alien control to estimate cross-contamination rates.

Interpreting Negative Control Results

A negative control that shows no detectable microbial reads indicates a clean workflow. A negative control with microbial reads indicates contamination, and the taxonomic composition of those reads should be compared with the composition of experimental samples. Taxa present in both negative controls and experimental samples are suspect, especially if they are more abundant in controls than in samples.

The Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics study established a framework integrating negative controls, lab-specific contaminant watchlists, and computational filtering. This framework substantially improved contamination management, reducing false-positive signals and enhancing viral genome recovery. The study also provides an open-source contaminants watchlist that laboratories can adapt to their own workflows.

Computational Decontamination Tools

Several computational tools detect and remove contamination from metagenomic datasets. Each tool has different requirements, strengths, and limitations.

Decontam

Decontam is a widely used R package that identifies contaminant sequences based on two complementary strategies. The frequency method compares sequence prevalence and abundance in negative controls versus experimental samples. The prevalence method identifies sequences that appear more frequently in negative controls than in true samples. Decontam requires negative controls and works best when contamination is consistent across the workflow.

Cont-ID

Cont-ID is a bioinformatic tool designed to check for cross-contamination by analyzing the relative abundance of virus sequencing reads and their duplication between samples. It can be applied when samples in a sequencing batch have been processed in parallel in the laboratory and with at least one Alien control. Using 273 real datasets including 68 virus species from different hosts and several library preparation protocols, Cont-ID classified with high accuracy (91%) whether viral species detection represented true infection or cross-contamination.

CroCoDeEL

CroCoDeEL is a decision-support tool for detecting and quantifying cross-sample contamination without requiring negative controls or prior knowledge of sample processing positions. It leverages linear modeling and a pre-trained supervised model to identify specific contamination patterns in species abundance profiles. Benchmarks across three public datasets demonstrated that CroCoDeEL can detect contaminated samples and identify their contamination sources, even at low rates below 0.1%, provided sufficient sequencing depth. Application of CroCoDeEL to existing studies revealed previously undetected contamination.

ContScout

ContScout is designed for eliminating foreign sequences from annotated genomes instead of raw metagenomic reads. It achieves high specificity and sensitivity on synthetic benchmark data even when the contaminant is a closely related species, and it can distinguish horizontal gene transfer from contamination. A screen of 844 eukaryotic genomes identified bacteria as the most common contamination source, followed by fungi and plants.

Recentrifuge

Recentrifuge implements a robust method for the removal of negative-control and crossover taxa from the rest of samples. It enables researchers to analyze results from taxonomic classifiers using interactive charts with emphasis on the confidence level of classifications. Recentrifuge provides shared and exclusive taxa per sample, enabling robust contamination removal and comparative analysis in environmental and clinical metagenomics.

Quality Control Protocols

Standard quality control for metagenomics data includes removing low quality reads and host contamination reads. The Quality control for metagenomics data protocol describes a stepwise approach that can be adapted to different sequencing platforms and study types.

At a Glance: Contamination Control Decision Table

Practical Workflow for Contamination Control

A contamination-aware workflow integrates prevention, detection, and computational filtering at every stage.

Step 1: Design the Experiment with Controls

Include negative controls at every processing stage. For low biomass samples, include multiple extraction blanks and at least one Alien control per batch. Document sample processing order and positions so that cross-contamination patterns can be investigated if problems arise.

Step 2: Prevent Contamination in the Laboratory

Work in a dedicated clean area for low biomass samples. Use filter tips, sterile reagents, and dedicated equipment. Clean surfaces with DNA-degrading agents. Separate pre-amplification and post-amplification areas to prevent PCR product carryover. For clinical samples, follow biosafety guidelines appropriate for the specimen type.

Step 3: Monitor Extraction and Library Preparation

Record reagent lot numbers, extraction dates, and technician identities. If possible, test new reagent lots before using them on valuable samples. For urine samples, a study evaluating urine volume and host depletion methods found that at least 3.0 mL of urine resulted in the most consistent urobiome profiling, and the DNA Microbiome extraction method yielded the greatest microbial diversity and maximized metagenome-assembled genome recovery while effectively depleting host DNA (Evaluating urine volume and host depletion methods to enable genome-resolved metagenomics of the urobiome). These findings illustrate that extraction method choice directly affects contamination and host DNA levels.

Step 4: Sequence with Appropriate Controls

Include negative controls in the sequencing run. Use unique dual indexes to minimize index hopping. If possible, sequence samples from the same study in the same run to reduce batch effects.

Step 5: Run Computational Quality Control

Remove low quality reads and host contamination reads using standard quality control protocols. Assess read quality metrics, adapter contamination, and duplication rates. Compare taxonomic profiles of negative controls with experimental samples.

Step 6: Apply Decontamination Tools

Use Decontam or Recentrifuge when negative controls are available. Use CroCoDeEL when negative controls are absent or when you suspect cross-contamination between samples. Use Cont-ID for viral metagenomic datasets with Alien controls.

Step 7: Validate and Document

Document all contamination control steps in your analysis pipeline. Report negative control results and decontamination parameters in publications and data repositories. The Genomic Data Sharing Policy from the National Institutes of Health requires that data sharing be consistent with informed consent and that privacy protections be maintained. The FAIR Guiding Principles emphasize that data should be findable, accessible, interoperable, and reusable, which includes documenting contamination control measures.

Records and Measurements for Contamination Monitoring

Maintaining detailed records is essential for identifying contamination sources and demonstrating data quality.

Essential Records

• Reagent lot numbers and expiration dates
• Extraction dates and technician identifiers
• Negative control identifiers and processing details
• Sequencing run information including instrument and flow cell
• Index assignments and sample positions
• Software versions and parameters for all analysis steps

Key Measurements

• DNA concentration and purity for each sample and control
• Sequencing depth and read quality metrics
• Negative control read counts and taxonomic composition
• Contamination score or proportion for each sample
• Ratio of contaminant reads to total reads

The A Comprehensive Assessment of Metagenomic cfDNA Sequencing for Microbe Detection study evaluated metagenomic cell-free DNA sequencing across 130 laboratories using a reference panel of 18 microbial communities. Most contamination originated from wet labs, as 68.25% of false-positive sequences matched reported microorganisms, while the chief cause of false-negative errors was from dry labs. This finding underscores that contamination control requires attention to both laboratory procedures and bioinformatics analysis.

Common Failure Patterns in Contamination Control

Understanding typical failure patterns helps you diagnose problems quickly.

Failure Pattern 1: Ignoring Negative Controls

Some researchers omit negative controls to save cost or because they assume reagents are clean. This is the most common and most damaging failure. Without negative controls, you cannot distinguish true signals from contamination, and you cannot apply Decontam or Recentrifuge effectively.

Failure Pattern 2: Processing Low Biomass Samples with High Biomass Samples

Low biomass samples are disproportionately affected by contamination from high biomass samples processed in the same batch. If you must process both, use separate extraction batches and include dedicated negative controls for the low biomass samples.

Failure Pattern 3: Using Only One Decontamination Method

Different contamination sources require different detection methods. Relying solely on negative control subtraction misses cross-contamination between samples. Relying solely on cross-contamination detection misses reagent contamination. Use multiple complementary approaches.

Failure Pattern 4: Overlooking Host DNA

Host DNA can dominate sequencing output, reducing sensitivity for microbial detection. The Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges review notes that mNGS requires a sufficient amount of microbial nucleic acid to be present in the sample tested, and false negatives can occur when microbial nucleic acid is below the detection threshold. Host depletion methods can improve sensitivity but may introduce their own biases.

Failure Pattern 5: Inadequate Sequencing Depth

Low sequencing depth reduces the ability to distinguish true signals from contamination. The CroCoDeEL study demonstrated detection of contamination at rates below 0.1% provided sufficient sequencing depth. If depth is inadequate, low-level contamination can be missed or true signals can be dismissed as contamination.

Failure Pattern 6: Ignoring Batch Effects

Samples processed in different batches or on different sequencing runs may have different contamination profiles. Combining data across batches without accounting for batch effects can produce spurious associations.

Limitations of Contamination Detection and Removal

Contamination detection and removal methods have important limitations that affect interpretation.

Detection Thresholds

No method can detect all contamination. Very low levels of contamination may be below the detection threshold of both experimental and computational methods. The Cont-ID study emphasizes that a detection threshold informed by estimated cross-contamination is mandatory, but this threshold may exclude genuine low-level signals.

Reference Database Dependence

Taxonomic classification depends on reference databases. Organisms absent from databases cannot be identified, and closely related species may be misclassified. The Evaluation of computational phage detection tools for metagenomic datasets study found that tools using homology approaches demonstrated low false positive rates and robustness to eukaryotic contamination, while tools using sequence composition approaches had higher sensitivity including to phages with less representation in reference databases. Tool choice therefore affects both contamination detection and biological conclusions.

Distinguishing Contamination from Biology

Some organisms detected in negative controls may also be genuine members of the sample community. Skin commensals, for example, may contaminate samples but may also be present in the sampled environment. Computational tools cannot always distinguish these cases, and biological interpretation is required.

Horizontal Gene Transfer

In genome analysis, distinguishing contamination from horizontal gene transfer is challenging. ContScout can distinguish horizontal gene transfer from contamination, but this capability is not universal across tools.

Quality and Welfare Context

Contamination control has direct implications for data quality, research integrity, and clinical decision-making.

Research Integrity

The FAIR Guiding Principles require that data be reusable, which means that contamination control measures must be documented and reported. The Genomic Data Sharing Policy similarly requires that data sharing be conducted responsibly. Failing to report contamination control measures undermines data reusability and can lead to incorrect conclusions by secondary data users.

Clinical Decision-Making

In clinical metagenomics, contamination can lead to false-positive pathogen detection and inappropriate treatment. The Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections review notes that clinicians interpreting mNGS results must be aware of false positives, as mNGS detects environmental microbes and their nucleic acids despite best practices to minimize contamination. Contamination control is therefore a patient safety issue.

Environmental and Agricultural Applications

Metagenomics is used to study microbial communities in soil, water, and agricultural systems. The Novel enzymes for biodegradation of polycyclic aromatic hydrocarbons identified by metagenomics study demonstrates how metagenome mining can identify enzymes for bioremediation. The Exploring the diversity and functional profile of microbial communities of Brazilian soils with high salinity and oil contamination study shows how contaminated soils can be characterized. In these applications, contamination control ensures that detected organisms and functions genuinely reflect the sampled environment instead of laboratory artifacts.

Professional Escalation Criteria

Some contamination problems require escalation to a supervisor, collaborator, or laboratory manager.

Escalate When

• Negative controls show high or unexpected contamination that cannot be traced to a specific reagent or step
• Contamination persists after implementing recommended prevention measures
• Cross-contamination is suspected between clinical samples where results affect patient care
• Contamination levels are so high that decontamination tools cannot reliably separate signal from noise
• You are asked to interpret results from a dataset with inadequate negative controls
• You discover contamination in a published dataset that you are reanalyzing

What to Report

When escalating, provide specific information including the contamination source if identified, the affected samples, the taxonomic composition of contaminants, the methods used for detection, and the impact on study conclusions. This information allows supervisors to make informed decisions about whether to repeat experiments, apply additional computational filtering, or exclude affected samples.

Frequently Asked Questions

What is the most common source of contamination in metagenomic datasets?

Reagent contamination is the most common source, particularly in low microbial biomass studies. DNA extraction kits and other commercial reagents can contain detectable levels of microbial DNA. The Contamination in Low Microbial Biomass Microbiome Studies review describes how contaminant DNA arises within microbiome studies and its negative impacts. Cross-sample contamination is also common when samples are processed in parallel.

How many negative controls should I include in a metagenomic experiment?

The number depends on your sample type and study design. For low biomass samples, include multiple extraction blanks and at least one Alien control per batch. The Cont-ID tool requires at least one Alien control to estimate cross-contamination rates. More controls are better for detecting low-level contamination, but cost and throughput constraints apply.

Can I detect contamination without negative controls?

Yes, but with limitations. CroCoDeEL detects cross-sample contamination without requiring negative controls or prior knowledge of sample processing positions. However, reagent contamination and laboratory environment contamination are difficult to detect without negative controls. If you have no negative controls, interpret results with caution and consider repeating the experiment with proper controls.

How do I distinguish contamination from genuine biological signals?

Compare the taxonomic composition of negative controls with experimental samples. Taxa present in both are suspect, especially if more abundant in controls. Use Decontam or Recentrifuge to subtract control taxa. Consider the biology of the detected organisms. For example, skin commensals in a skin swab sample are expected, but the same organisms in cerebrospinal fluid may indicate contamination.

What is the difference between Decontam and CroCoDeEL?

Decontam requires negative controls and identifies contaminant sequences based on frequency and prevalence patterns in controls versus samples. CroCoDeEL does not require negative controls and detects cross-sample contamination by identifying specific contamination patterns in species abundance profiles. Use Decontam when you have good negative controls. Use CroCoDeEL when controls are absent or when you suspect cross-contamination between samples.

How does host DNA affect contamination detection?

Host DNA can dominate sequencing output, reducing sensitivity for microbial detection and making contamination relatively more prominent. Host depletion methods can improve sensitivity but may introduce their own biases. The Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections review notes that mNGS requires sufficient microbial nucleic acid in the sample, and false negatives can occur when microbial nucleic acid is below the detection threshold.

What should I do if my negative controls show contamination?

First, identify the source. Check reagent lot numbers, review extraction procedures, and inspect laboratory conditions. If the contamination is from a specific reagent, replace it and repeat the extraction. If the contamination is environmental, clean the workspace and repeat. If contamination persists, escalate to your supervisor. For samples already sequenced, apply computational decontamination tools and document the contamination in your analysis report.

How should I report contamination control in my publications?

Report the number and types of negative controls, the contamination levels detected, the decontamination tools and parameters used, and the impact of contamination on study conclusions. The FAIR Guiding Principles require that data be reusable, which includes documenting contamination control measures. The Genomic Data Sharing Policy provides additional guidance on responsible data sharing.

Related Bioinformatics Guides

• FASTQ File Format: Decoding Phred Quality Scores and Quality Control Workflows
• Variant Calling Pipelines: GATK Best Practices, FreeBayes, and DeepVariant Comparison
• Querying Sequence Databases: Best Practices for Formatting FASTA Sequences in BLAST Searches
• The Protein Data Bank (PDB): Archival Standards, Structural Validation Metrics, and Bioinformatics Integration Protocols
• Homology Modeling: Principles and Practices

References and Further Reading

• EMBL-EBI Training. European Bioinformatics Institute.
• NCBI Data Resources. National Center for Biotechnology Information.
• Genomic Data Sharing Policy. National Institutes of Health.
• The FAIR Guiding Principles. Scientific Data.
• Cont-ID: detection of sample cross-contamination in viral metagenomic data.. BMC biology, 2023.
• Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations.. Trends in microbiology, 2019.
• Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges.. Molecular diagnosis & therapy, 2024.
• CroCoDeEL: accurate control-free detection of cross-sample contamination in metagenomic data.. Nature communications, 2026.
• A Comprehensive Assessment of Metagenomic cfDNA Sequencing for Microbe Detection.. Clinical chemistry, 2025.
• ContScout: sensitive detection and removal of contamination from annotated genomes.. Nature communications, 2024.
• Evaluation of computational phage detection tools for metagenomic datasets.. Frontiers in microbiology, 2023.
• Metagenomic Detection of Divergent Insect- and Bat-Associated Viruses in Plasma from Two African Individuals Enrolled in Blood-Borne Surveillance.. Viruses, 2023.
• Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.. 2026.
• Evaluating urine volume and host depletion methods to enable genome-resolved metagenomics of the urobiome.. 2025.
• The impact of tuberculosis and its treatment on the lung and gut microbiota: a global systematic review, meta-analysis, and amplicon-based metagenomic meta-analysis.. 2025.
• Bronchoalveolar lavage fluid metagenomic datasets: a multidimensional clinical biomolecular resource.. 2025.
• Assessment of air infectious contamination during wound care in a burn intensive care unit using Shotgun metagenomics.. American Journal of Infection Control, 2025.
• Recentrifuge: Robust comparative analysis and contamination removal for metagenomics. PLoS Comput. Biol., 2019.
• Quality control for metagenomics data v1. 2020.
• Novel enzymes for biodegradation of polycyclic aromatic hydrocarbons identified by metagenomics and functional analysis in short-term soil microcosm experiments. Scientific Reports, 2024.
• A Review of Antibiotics, Antibiotic Resistant Bacteria, and Resistance Genes in Aquaculture: Occurrence, Contamination, and Transmission. Toxics, 2023.
• Exploring the diversity and functional profile of microbial communities of Brazilian soils with high salinity and oil contamination. Heliyon, 2024.
• CLINICAL METAGENOMICS IN MICROBIOLOGY DIAGNOSTICS: ANALYTICAL CHALLENGES, QUALITY ASSURANCE, AND EMERGING FUTURE-READY APPROACHES. American Journal of Medical and Natural Sciences, 2026.
• Metagenomics combined with metabolomics reveals the effect of Enterobacter sp. inoculation on the rhizosphere microenvironment of Bidens pilosa L. in heavy metal contaminated soil.. Journal of Hazardous Materials, 2023.
• Sensitivity of next-generation sequencing metagenomic analysis for detection of RNA and DNA viruses in cerebrospinal fluid: The confounding effect of background contamination. Advances in Experimental Medicine and Biology, 2017.
• Study of Metagenomic Sequencing Technology to Detect Microbial Contamination on the Surface of Chrysanthemi Flos. Chinese Journal of Modern Applied Pharmacy, 2022.
• Insights into Microbial Communities and Foodborne Pathogens in Food Samples from Kinta Valley, Perak, Malaysia through Metagenomic Analysis. Iop Conference Series Earth and Environmental Science, 2024.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.